# Insights into organelle forming RNAs: Diversity, functions and future perspectives

**Authors:** Meng Gong, Xiangting Wang, Xiaolin Liang

PMC · DOI: 10.1002/ame2.70080 · Animal Models and Experimental Medicine · 2025-11-28

## TL;DR

This paper reviews how certain RNAs directly form cellular structures and organelles, expanding their known roles beyond gene regulation.

## Contribution

The paper introduces the concept of 'organelle formation RNAs' and highlights their structural roles in cellular subunits.

## Key findings

- RNA molecules like TubAR are structural components of the cytoskeleton.
- Paraspeckle-forming, nuclear speckle-forming, and nucleolus-forming RNAs contribute to distinct cellular structures.
- Understanding these RNAs may lead to new therapeutic approaches for related diseases.

## Abstract

RNA molecules play diverse and essential roles in cellular processes beyond their well‐known functions in gene expression and regulation. While ribosomal RNAs (rRNAs) have long been recognized as structural components of ribosomes, recent research has highlighted the importance of a distinct group of RNAs which directly compose the structures or organelles in mammalian cells. We refer to these as ‘organelle formation RNAs’. Specifically, the discovery of tubulin‐associated lncRNA (TubAR), the first identified cytoskeleton‐forming RNA, has expanded our understanding of RNA functionality; we now recognize ‘organelle formation RNAs’ not only as regulatory molecules but also as direct structural components within cellular subunits. Other ‘organelle formation RNAs’ include paraspeckle‐forming RNAs, nuclear speckle‐forming RNAs, and nucleolus‐forming RNAs. Various RNAs contribute to the formation of distinct cellular structures, while also participating in intricate intermolecular interactions. Understanding these molecules not only uncovers their fundamental roles in cellular physiology but also suggests potential applications in the treatment of related diseases. By examining the latest advancements and methodologies in organelle formation RNA research, this review provides a comprehensive overview of the intricate mechanisms of these RNAs and future directions in the field.

RNA molecules play crucial roles in the formation and maintenance of cellular structures and organelles. These ‘organelle formation RNAs’ include ribosomal RNAs, paraspeckle‐forming RNAs, nuclear speckle‐forming RNAs, nucleolus‐forming RNAs, and cytoskeleton‐forming RNA. This review explores their structural characteristics, functions, and potential implications for health and disease.

## Full-text entities

- **Genes:** Grin2b (glutamate receptor, ionotropic, NMDA2B (epsilon 2)) [NCBI Gene 14812] {aka GluN2B, GluRepsilon2, NR2B, Nmdar2b}, Hsf1 (heat shock factor 1) [NCBI Gene 15499] {aka HSTF, HSTF 1, Hsf1alpha, Hsf1beta}, Malat1 (metastasis associated lung adenocarcinoma transcript 1 (non-coding RNA)) [NCBI Gene 72289] {aka 2210401K01Rik, 9430072K23Rik, Neat2}, Nlrp3 (NLR family, pyrin domain containing 3) [NCBI Gene 216799] {aka AGTAVPRL, AII/AVP, Cias1, FCAS, FCU, MWS}, Kras (Kras proto-oncogene, GTPase) [NCBI Gene 16653] {aka K-Ras, K-Ras 2, K-ras, Ki-ras, Kras-2, Kras2}, Tubb4a (tubulin, beta 4A class IVA) [NCBI Gene 22153] {aka M(beta)4, Tubb, Tubb4}, Ubtf (upstream binding transcription factor, RNA polymerase I) [NCBI Gene 21429] {aka A930005G04Rik, NOR-90, Tcfubf, UBF, UBF-1, UBF1}, Fus (fused in sarcoma) [NCBI Gene 233908] {aka D430004D17Rik, D930039C12Rik, Fus1, Tls}, Nedd4l (neural precursor cell expressed, developmentally down-regulated gene 4-like) [NCBI Gene 83814] {aka 1300012C07Rik, NEDD4.2, Nedd4-2, Nedd4b}, Nucleolin (nucleolin multifunctional protein) [NCBI Gene 17975] {aka B530004O11Rik, C23, D0Nds28, D1Nds28, Ncl, Nucl}, Pink1 (PTEN induced putative kinase 1) [NCBI Gene 68943] {aka 1190006F07Rik, BRPK, mFLJ00387}, Npm1 (nucleophosmin 1) [NCBI Gene 18148] {aka B23, NO38, Npm}, Neat1 (nuclear paraspeckle assembly transcript 1 (non-protein coding)) [NCBI Gene 66961] {aka 2310043N10Rik, VINC}, Nono (non-POU-domain-containing, octamer binding protein) [NCBI Gene 53610] {aka NRB54, P54NRB, nonA}, Men1 (multiple endocrine neoplasia 1) [NCBI Gene 17283], Serpinb6b (serine (or cysteine) peptidase inhibitor, clade B, member 6b) [NCBI Gene 20708] {aka NK13, Spi12, ovalbumin}, Psen1 (presenilin 1) [NCBI Gene 19164] {aka Ad3h, PS-1, PS1, S182}, Tardbp (TAR DNA binding protein) [NCBI Gene 230908] {aka 1190002A23Rik, TDP-43, Tdp43}, Ptbp1 (polypyrimidine tract binding protein 1) [NCBI Gene 19205] {aka HNRPI, PTB-1, PTB2, PTB3, PTB4, Ptb}, Mir376b (microRNA 376b) [NCBI Gene 723934] {aka Mirn376b, mir-376b}, Nsun5 (NOL1/NOP2/Sun domain family, member 5) [NCBI Gene 100609] {aka 9830109N13Rik, Nol1r, Wbscr20, Wbscr20a}, Tuba1a (tubulin, alpha 1A) [NCBI Gene 22142] {aka Tuba-1, Tuba1}, Cstf3 (cleavage stimulation factor, 3' pre-RNA, subunit 3) [NCBI Gene 228410] {aka 4732468G05Rik, CstF-77}, Rpph1 (ribonuclease P RNA component H1) [NCBI Gene 85029] {aka Gm24821, H1RNA, Rmrp5, Rpr}, Sfpq (splicing factor proline/glutamine rich (polypyrimidine tract binding protein associated)) [NCBI Gene 71514] {aka 1110004P21Rik, 2810416M14Rik, 5730453G22Rik, 9030402K04Rik, D4Ertd314e, Gm12940}, Ythdc1 (YTH domain containing 1) [NCBI Gene 231386] {aka A730098D12Rik, mKIAA1966}, Lama3 (laminin, alpha 3) [NCBI Gene 16774] {aka Lama3B, [a]3B}, Fbl (fibrillarin) [NCBI Gene 14113] {aka FIB, FLRN, RNU3IP1}, Poli (polymerase (DNA directed), iota) [NCBI Gene 26447] {aka Rad30b}
- **Diseases:** demyelination (MESH:D003711), cystic lesions (MESH:D052177), gliosis (MESH:D005911), metastasis (MESH:D009362), embryonic lethality (MESH:D020964), retinal vascular damage (MESH:D012164), ovarian cancer (MESH:D010051), breast cancer (MESH:D001943), cognitive deficits (MESH:D003072), malformations (MESH:C564254), Parkinson's disease (MESH:D010300), developmental and degenerative diseases (MESH:D019636), pancreatic intraepithelial neoplasias (MESH:D002578), diabetic (MESH:D003920), cancer (MESH:D009369), locomotor deficits (MESH:D001523), Alzheimer's disease (MESH:D000544), multiple myeloma (MESH:D009101), ANIMAL MODELS (MESH:D004195), tumorigenesis (MESH:D063646), hypoxic (MESH:D002534), non-small-cell lung cancer (MESH:D002289), hematological malignancies (MESH:D019337)
- **Chemicals:** LoNA (-), lenalidomide (MESH:D000077269), MPTP (MESH:D015632), m6A (MESH:C005955), platinum (MESH:D010984), N6-methyladenosine (MESH:C010223), STZ (MESH:D013311)
- **Species:** Danio rerio (leopard danio, species) [taxon 7955], Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116], Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** N414K, G12D, A3A, D249N, R282P, V255I
- **Cell lines:** hAPP-J20 — Mus musculus (Mouse), Mouse reticulum cell sarcoma, Cancer cell line (CVCL_D138)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12884421/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12884421/full.md

## References

86 references — full list in the complete paper: https://tomesphere.com/paper/PMC12884421/full.md

---
Source: https://tomesphere.com/paper/PMC12884421